This article highlights studies that may help inform cancer prevention efforts as well as the treatment of various cancers.

Americans across the political spectrum want more investment in medical research, not less,” said ASH President Belinda R. Avalos, MD.

GO-PIMs are prevalent in patients with cancer treated in a national health care system, with increasing GO-PIMs independently linked to frailty and worse clinical outcomes,” the researchers wrote.

Antibiotic prescription is mandatory in case of serious infection, but the choice of antibiotic could be oriented toward ... drugs without an association with survival,” the researchers wrote.

Researchers found the incidence of anal cancer is highest for cervical cancer survivors who are 65-75 years of age.

The FDA says it is taking new steps to eliminate misleading direct-to-consumer drug ads out of concern that patients are not receiving a "fair balance" of information on pharmaceutical products.

The FDA has granted breakthrough therapy designation to SER-155 for the reduction of bloodstream infections in adults undergoing allogeneic hematopoietic stem cell transplant.

These findings support the integration of PRO assessments into clinical decision-making and risk stratification in oncology,” the researchers concluded.

Under President Donald Trump, leaders at the US Food and Drug Administration (FDA) are moving to abandon a decades-old policy of asking outside experts to review drug applications, a move critics say ...

A history of moderate to severe traumatic brain injury is associated with an increased risk of malignant brain tumors, data suggest.

Our findings continue to highlight the complex landscape of cancer care costs and call for further research and policy changes,” the researchers wrote.